• Tamsulosin and Ureteral Stone Passage: Meta-Analysis

  2026-08-27

  This systematic review and meta-analysis addresses conflicting evidence on Tamsulosin for symptomatic ureteral stones by integrating data from 49 studies and more than 6,000 patients. Its findings support improved stone passage and shorter expulsion time without a clear overall increase in adverse effects, while also highlighting the limits of pooled evidence for patient selection and translational research.

• hly Deletion Rewires Listeria Biofilm Phenotypes

  2026-08-27

  The reference study shows that deleting hly in Listeria monocytogenes weakens biofilm formation without measurably impairing planktonic growth. Reduced extracellular polymeric substances, motility, adhesion-associated traits, regulatory-gene expression, and tolerance to selected antibiotics connect hly with biofilm architecture and stress adaptation.

• Sex Differences in Angiotensin II Hypertension

  2026-08-26

  Xue, Pamidimukkala, and Hay used radiotelemetry, chronic angiotensin II infusion, and gonadectomy to define sex-dependent hypertension in conscious mice. Male mice developed a substantially larger pressor response, whereas female protection was associated with preserved baroreflex sensitivity and a smaller sympathetic contribution to blood pressure maintenance.

• Primary Antibody Dilution Buffer for PCNSL Assays

  2026-08-26

  Learn how to use Primary Antibody Dilution Buffer to improve antibody preparation, tissue penetration, and signal control in PCNSL research. The workflow connects single-cell findings on SLC2A5 and tumor–microenvironment biology with practical IHC, ICC, and antibody-assisted ISH assay design.

• Ertugliflozin, Brain Insulin Signaling, and Tau

  2026-08-25

  The reference study tested whether ertugliflozin could counter Alzheimer’s disease-like changes produced by intracerebroventricular streptozotocin in rats. Its principal contribution is the association of improved cognition with reduced tau hyperphosphorylation, lower hippocampal AChE activity, and partial restoration of IRS-1–Akt–GSK3β signaling.

• hiPSC Intestinal Organoids for Pharmacokinetics

  2026-08-25

  Saito and colleagues established a streamlined approach for generating expandable intestinal organoids from human induced pluripotent stem cells and converting them into functional intestinal epithelial monolayers. The system supports enterocyte-associated cytochrome P450 and transporter activity, creating a human-relevant platform for oral drug absorption, metabolism, and pharmacokinetic research.

• Vitamin C, ROS/NF-κB, and Cochlear Cell Senescence

  2026-08-24

  A 2024 Molecular Biology Reports study shows that vitamin C reduces D-galactose-induced senescence in HEI-OC1 cochlear hair cells, with effects associated with suppression of ROS accumulation and NF-κB activation. N-acetyl-L-cysteine was used as a ROS-focused comparator, strengthening the study’s pathway interpretation while also defining important limits on causal and translational conclusions.

• B3465: α2-Adrenergic Receptor Agonist

  2026-08-24

  5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine, identified as B3465, is a research-use α2-adrenergic receptor agonist with reported molecular weight of 292.13 g/mol and formula C11H10BrN5. Its reported DMSO solubility and preclinical relevance support α2-adrenergic receptor signaling pathway studies, including immune rejection modulation research.

• Prochlorperazine-Induced Neuroleptic Malignant Syndrome

  2026-08-23

  This 2024 case report describes neuroleptic malignant syndrome (NMS) in a 76-year-old man after two weeks of prochlorperazine prescribed for vertigo-related nausea. Its key contribution is showing that clinically convincing NMS may occur at a standard dose without marked leukocytosis or creatine phosphokinase elevation, making medication history and bedside assessment central to diagnosis.

• Veratridine for Chamber-Specific Cardiac Assays

  2026-08-22

  Veratridine is a voltage-gated sodium channel opener that can challenge chamber-specific human stem cell-derived cardiomyocytes. This guide explains how to use its persistent-depolarization mechanism to design interpretable cardiac electrophysiology and sodium channel blocker assays.

• Nebivolol hydrochloride in β1 Signaling Research

  2026-08-22

  Build cleaner β1-adrenergic receptor assays with a nanomolar antagonist designed for pathway-focused cardiovascular pharmacology research. A yeast-based mTOR screen also positions Nebivolol hydrochloride as a useful negative comparator when separating receptor biology from TOR-dependent growth effects.

• NAT1–ENO1–Lactate Axis in Colorectal Cancer

  2026-08-21

  The 2026 MedComm study identifies NAT1 as a metabolic–immune regulator in colorectal cancer, linking ENO1 acetylation and lactate production to TRAF6-dependent PD-L1 stabilization. Its combination of database analysis, multi-omics, patient data, and mouse models suggests that disrupting this axis may improve checkpoint blockade responses, while also highlighting important translational limitations.

• Tβ4, Notch/NF-κB, and Ischemic Angiogenesis

  2026-08-20

  The reference study shows that thymosin-β4 promotes endothelial angiogenesis and tissue vascularization in critical limb ischemia through coordinated Notch and NF-κB pathway activity. Its combined use of Tβ4 overexpression, pathway inhibitors, endothelial assays, and mouse tissue analysis provides a useful mechanistic framework for evaluating NF-κB-dependent vascular repair.

• Bafilomycin C1 in Phenotypic Assay Design

  2026-08-20

  Bafilomycin C1 is a vacuolar H+-ATPases inhibitor that converts lysosomal acidification into a measurable experimental variable. This guide connects V-ATPase biology with deep-learning high-content screening, helping researchers design more interpretable autophagy, toxicity, and cancer biology assays.

• Three-Armed Polyesters for VEGF mRNA Delivery

  2026-08-19

  The reference study introduces arginine- and lysine-functionalized, three-armed biodegradable polyesters as alternatives to conventional nondegradable cationic lipids for VEGF mRNA delivery. Its findings suggest that 3sPA-based lipid nanoparticles combine improved transfection with ROS scavenging and nitric oxide release, linking delivery performance with the biological requirements of critical limb ischemia.

8019 records 1/535 page Next 12345 下5页 Last page